Log In
Print
BCIQ
Print
Print this Print this
 

HLD-200

  Manage Alerts
Collapse Summary General Information
Company Highland Therapeutics Inc.
DescriptionModified-release formulation of the generic methylphenidate
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase I/II
Standard IndicationAttention deficit hyperactivity disorder (ADHD)
Indication DetailsTreat ADHD
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today